ArticleBMC endocrine disorders2021

The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile.

Anna Thorsø Larsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.